dexmedetomidine has been researched along with Clerambault Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, T; Liu, C; Wang, J; Xin, Y; Xu, A | 1 |
| Leng, Y; Wang, Y; Yu, S; Zhao, G | 1 |
| Cheng, Y; Xue, FS; Yuan, YJ | 1 |
| Kii, N; Sawada, A; Tachibana, S; Yamakage, M; Yoshikawa, Y | 1 |
| Böhm, L; Helbing, DL; Witte, OW | 1 |
1 review(s) available for dexmedetomidine and Clerambault Syndrome
| Article | Year |
|---|---|
A Review of the Biological Mechanisms of Dexmedetomidine for Postoperative Neurocognitive Disorders.
Topics: Adjuvants, Anesthesia; Aged; Delirium; Dexmedetomidine; Humans; Neurocognitive Disorders; Postoperative Cognitive Complications | 2022 |
4 other study(ies) available for dexmedetomidine and Clerambault Syndrome
| Article | Year |
|---|---|
Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-κB signaling pathway.
Topics: Animals; Dexmedetomidine; Hippocampus; HMGB1 Protein; Neurocognitive Disorders; Neuroinflammatory Diseases; Neuroprotective Agents; NF-kappa B; Rats; Receptor for Advanced Glycation End Products; Receptors, Adrenergic; Signal Transduction; Yohimbine | 2022 |
Assessing Benefit of Dexmedetomidine on Postoperative Neurocognitive Disorders: Important Issues That Should Be Acknowledged.
Topics: Cognition; Dexmedetomidine; Humans; Inflammation; Neurocognitive Disorders; Prospective Studies | 2020 |
Dexmedetomidine Ameliorates Perioperative Neurocognitive Disorders by Suppressing Monocyte-Derived Macrophages in Mice With Preexisting Traumatic Brain Injury.
Topics: Animals; Brain Injuries, Traumatic; Dexmedetomidine; Humans; Interleukin-1beta; Macrophages; Male; Mice; Mice, Inbred C57BL; Neurocognitive Disorders | 2022 |
Sepsis-associated encephalopathy.
Topics: Critical Care; Delirium; Dexmedetomidine; Guidelines as Topic; Humans; Hypnotics and Sedatives; Muscular Diseases; Neurocognitive Disorders; Organ Dysfunction Scores; Polyneuropathies; Sepsis-Associated Encephalopathy | 2018 |